Translation Services USA

ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


ValiRx PLC.
109 announcements.
Time Ticker Company Announcement
14:05 VAL ValiRx PLC
Second Price Monitoring Extn
14:00 VAL ValiRx PLC
Price Monitoring Extension
12:07 VAL ValiRx PLC
Result of General Meeting & working capital update
07:00 VAL ValiRx PLC
Change of Venue for General Meeting-17 Feb 2020
14:00 VAL ValiRx PLC
Posting of Circular & Notice of General Meeting
07:00 VAL ValiRx PLC
Update - ValiSeek
07:00 VAL ValiRx PLC
Placing, Issue of Warrant & Appointment of Broker
09:05 VAL ValiRx PLC
Second Price Monitoring Extn
09:00 VAL ValiRx PLC
Price Monitoring Extension
07:00 VAL ValiRx PLC
VAL201 Update
07:00 VAL ValiRx PLC
US Patent Grant re VAL201 & Metastatic Cancer
11:33 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Appointment of Joint Broker
15:30 VAL ValiRx PLC
Holding(s) in Company
11:47 VAL ValiRx PLC
Passing of Non-Executive Chairman
13:23 VAL ValiRx PLC
Placing & Issue of Equity
16:35 VAL ValiRx PLC
Price Monitoring Extension
07:00 VAL ValiRx PLC
Half-year Report
07:00 VAL ValiRx PLC
Company Update
17:15 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
VAL201 Update
07:00 VAL ValiRx PLC
Company Update & Change of Adviser
07:00 VAL ValiRx PLC
New European patent allowance for VAL301
16:02 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Appointment of Joint Broker
07:00 VAL ValiRx PLC
Marketing and Communications Update
11:14 VAL ValiRx PLC
Change of Registered Address
07:00 VAL ValiRx PLC
Update re VAL301
13:33 VAL ValiRx PLC
Holding(s) in Company
12:31 VAL ValiRx PLC
Issue of Equity
12:03 VAL ValiRx PLC
Result of AGM
12:00 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
US Notice of Allowance-VAL201 & Metastatic Cancer
14:50 VAL ValiRx PLC
Further re: Termination of Subscription Agreement
12:45 VAL ValiRx PLC
Holding(s) in Company
12:00 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Update on VAL201 Clinical Trial
12:00 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Placing, Subscription Agreement & Issue of Warrant
07:00 VAL ValiRx PLC
Subscription Agreement Update
07:00 VAL ValiRx PLC
Notice of AGM & Update of Subscription Agreement
11:07 VAL ValiRx PLC
Subscription Agreement Update
10:42 VAL ValiRx PLC
Holding(s) in Company
10:30 VAL ValiRx PLC
Holding(s) in Company
11:44 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Final Results
07:00 VAL ValiRx PLC
Subscription Agreement Update
12:02 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Subscription Agreement Update
14:00 VAL ValiRx PLC
Price Monitoring Extension
07:00 VAL ValiRx PLC
Acquisition of Intellectual Property& JV Agreement
14:06 VAL ValiRx PLC
Second Price Monitoring Extn
14:01 VAL ValiRx PLC
Price Monitoring Extension
11:07 VAL ValiRx PLC
Second Price Monitoring Extn
11:01 VAL ValiRx PLC
Price Monitoring Extension
10:55 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
Subscription, Convertible Funds and Warrant Issue
07:15 VAL Hardman & Co Research
Valirx (VAL): VAL401 is going forward
07:00 VAL ValiRx PLC
ValiSeek Update
07:00 VAL ValiRx PLC
Update on VAL201 & VAL301 Development Progress
11:22 VAL ValiRx PLC
Placing, Issue of Equity and Warrant
07:00 VAL ValiRx PLC
New patent grant allowances for VAL301
07:00 VAL ValiRx PLC
Publication of VAL401 peer-reviewed article
10:41 VAL ValiRx PLC
ValiRx endorses the Government's new NHS strategy
07:00 VAL ValiRx PLC
Holding(s) in Company
16:41 VAL ValiRx PLC
Second Price Monitoring Extn
16:36 VAL ValiRx PLC
Price Monitoring Extension
11:25 VAL ValiRx PLC
Issue of Equity / PDMR Shareholdings
07:00 VAL ValiRx PLC
Update on VAL401 - Peer-review Acceptance
07:00 VAL ValiRx PLC
Update on VAL201 Clinical Trial
07:00 VAL ValiRx PLC
Re scientific and investor meetings
07:15 VAL Hardman & Co Research
ValiRx (VAL): VAL401 Phase II trial completed
07:00 VAL ValiRx PLC
Align Research Initiates Coverage
07:00 VAL ValiRx PLC
VAL201 in concluding stages of Phase I/II trial
12:00 VAL ValiRx PLC
VAL401 results shortly to be on ClinicalTrials.gov
07:00 VAL ValiRx PLC
Half-year Report
12:42 VAL ValiRx PLC
Issue of Equity
07:00 VAL ValiRx PLC
Update on Clinical Development
12:17 VAL ValiRx PLC
Result of General Meeting
07:00 VAL ValiRx PLC
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
16:42 VAL ValiRx PLC
Notice of GM
07:00 VAL ValiRx PLC
VAL401 Update
09:00 VAL ValiRx PLC
Price Monitoring Extension
07:00 VAL ValiRx PLC
Exercise of Warrants and Issue of Equity
14:29 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
US Patent Notice of Allowance for Compound VAL201
07:00 VAL ValiRx PLC
ValiSeek Clinical Update (VAL401)
15:30 VAL ValiRx PLC
Holding(s) in Company
12:06 VAL ValiRx PLC
Holding(s) in Company
16:26 VAL ValiRx PLC
Holding(s) in Company
11:57 VAL ValiRx PLC
Issue of options and directors dealings
11:01 VAL ValiRx PLC
Statement re broker
15:01 VAL ValiRx PLC
Appointment of Broker
07:00 VAL ValiRx PLC
Holding(s) in Company
07:00 VAL ValiRx PLC
US Patent Grant for Therapeutic Compound, VAL201
07:00 VAL ValiRx PLC
Final Results
07:00 VAL ValiRx PLC
Notice of AGM
07:00 VAL ValiRx PLC
GENEICE & VAL101 Update
10:43 VAL Hardman & Co Research
ValiRx (VAL): 2017: a pivotal year
07:00 VAL ValiRx PLC
EU Patent Grant for Therapeutic Compound, VAL201
16:40 VAL ValiRx PLC
Second Price Monitoring Extn
16:35 VAL ValiRx PLC
Price Monitoring Extension
14:00 VAL ValiRx PLC
Price Monitoring Extension
14:05 VAL ValiRx PLC
Second Price Monitoring Extn
16:35 VAL ValiRx PLC
Price Monitoring Extension
16:40 VAL ValiRx PLC
Second Price Monitoring Extn
16:01 VAL ValiRx PLC
Placing and grant of warrants
12:13 VAL ValiRx PLC
Result of AGM
14:56 VAL ValiRx PLC
Holding(s) in Company